1286348

Haisco-USA Pharmaceuticals, Inc. — FEI 3039464114

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 9, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bridgewater, NJ (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748221 CFR 312.50General responsibilities of sponsors